middle.news
Cleo readies US lab for ovarian cancer test validation
9:02am on Thursday 12th of November, 2026 AEDT
•
Healthcare
Read Story
Cleo readies US lab for ovarian cancer test validation
9:02am on Thursday 12th of November, 2026 AEDT
Key Points
Three Ella instruments commissioned at CLIA-certified Asuragen laboratory
Inter-laboratory reproducibility studies underway between Melbourne and the US
Clinical Validation expected to begin within the next month
Approximately 1,470 samples across pivotal, specificity and healthy-individual studies
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE